Dexter Takes Over Wellcome Trust's Pot of Gold

See allHide authors and affiliations

Science  26 Jun 1998:
Vol. 280, Issue 5372, pp. 2043
DOI: 10.1126/science.280.5372.2043a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


LONDON-- Next week, Mike Dexter, one of Britain's most distinguished cell biologists, will takes the reins of the world's largest private fund for biomedical research, Britain's Wellcome Trust. Dexter takes over at a time when public funding for research is being consolidated at fewer departments; money for infrastructure is chronically scarce; the public research budget is stagnant; and a large cadre of researchers are marooned on short-term contracts. All of this has given the trust, with annual spending almost matching that of the government-funded Medical Research Council, enormous influence within Britain's biomedical science community (Science, 22 November 1996, p. 1292).